Details for New Drug Application (NDA): 021411

✉ Email this page to a colleague

NDA 021411 describes STRATTERA, which is a drug marketed by Lilly and is included in one NDA. It is available from one supplier. Additional details are available on the STRATTERA profile page.

The generic ingredient in STRATTERA is atomoxetine hydrochloride. There are sixteen drug master file entries for this compound. Nineteen suppliers are listed for this compound. Additional details are available on the atomoxetine hydrochloride profile page.

Summary for 021411

Tradename:	STRATTERA
Applicant:	Lilly
Ingredient:	atomoxetine hydrochloride
Patents:	0

Pharmacology for NDA: 021411

Mechanism of Action	Norepinephrine Uptake Inhibitors

Medical Subject Heading (MeSH) Categories for 021411

Adrenergic Uptake Inhibitors

Suppliers and Packaging for NDA: 021411

Tradename	Generic Name	Dosage	NDA	Application Type	Supplier	National Drug Code	Package Code	Package
STRATTERA	atomoxetine hydrochloride	CAPSULE;ORAL	021411	NDA	Eli Lilly and Company	0002-3227	0002-3227-30	30 CAPSULE in 1 BOTTLE (0002-3227-30)
STRATTERA	atomoxetine hydrochloride	CAPSULE;ORAL	021411	NDA	Eli Lilly and Company	0002-3228	0002-3228-30	30 CAPSULE in 1 BOTTLE (0002-3228-30)

Profile for product number 001

Active Rx/OTC/Discontinued:	DISCN	Dosage:	CAPSULE;ORAL			Strength	EQ 5MG BASE
Approval Date:	Nov 26, 2002	TE:		RLD:	No

Profile for product number 002

Active Rx/OTC/Discontinued:	RX	Dosage:	CAPSULE;ORAL			Strength	EQ 10MG BASE
Approval Date:	Nov 26, 2002	TE:	AB	RLD:	Yes

Profile for product number 003

Active Rx/OTC/Discontinued:	RX	Dosage:	CAPSULE;ORAL			Strength	EQ 18MG BASE
Approval Date:	Nov 26, 2002	TE:	AB	RLD:	Yes

Expired US Patents for NDA 021411

Subscribe to access the full database, or Sign Up
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	Patent No.	Patent Expiration
Lilly	STRATTERA	atomoxetine hydrochloride	CAPSULE;ORAL	021411-001	Nov 26, 2002	⤷ Sign Up	⤷ Sign Up
Lilly	STRATTERA	atomoxetine hydrochloride	CAPSULE;ORAL	021411-004	Nov 26, 2002	⤷ Sign Up	⤷ Sign Up
Lilly	STRATTERA	atomoxetine hydrochloride	CAPSULE;ORAL	021411-005	Nov 26, 2002	⤷ Sign Up	⤷ Sign Up
Lilly	STRATTERA	atomoxetine hydrochloride	CAPSULE;ORAL	021411-008	Feb 14, 2005	⤷ Sign Up	⤷ Sign Up
Lilly	STRATTERA	atomoxetine hydrochloride	CAPSULE;ORAL	021411-007	Feb 14, 2005	⤷ Sign Up	⤷ Sign Up
Lilly	STRATTERA	atomoxetine hydrochloride	CAPSULE;ORAL	021411-006	Nov 26, 2002	⤷ Sign Up	⤷ Sign Up
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>Patent No.	>Patent Expiration

Complete Access Available with Subscription

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.